Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_assertion type Assertion NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_head.
- NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_assertion description "[Although much progress has been made in understanding the molecular pathogenesis of myeloid neoplasms, most of the diseases included in the group of MDS/MPN still remain 'clinicopathologically assigned'.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_provenance.
- NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_assertion evidence source_evidence_literature NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_provenance.
- NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_assertion SIO_000772 18480833 NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_provenance.
- NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_assertion wasDerivedFrom befree-2016 NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_provenance.
- NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_assertion wasGeneratedBy ECO_0000203 NP671062.RAtwhBXSNXf4u9auKc_HJtq90My-RD_j2OTwg0qixvb-o130_provenance.